Latest / Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
PROTECT Data and Teplizumab in Newly Diagnosed T1D
In this episode, hosts discuss data from the PROTECT trial, which examined the effects of teplizumab on beta-cell function in patients with newly diagnosed type 1 diabetes.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.